Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Jiang, Guanchao ^a   Yang, Fan ^a   Li, Xiao ^a   Liu, Jun ^a   Li, Jianfeng ^a   Zhao, Hui ^a   Li, Yun ^a   Wang, Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Adjuvant chemotherapy; Lobectomy; Non small cell lung cancer (nsclc); Video assisted thoracoscopic surgery (vats)

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; ASTHENIA; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURGERY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; FATIGUE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPOTHESIS; INFECTION; INTERMETHOD COMPARISON; LENGTH OF STAY; LEUKOPENIA; LUNG FUNCTION; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; NEUTROPENIA; OPERATION DURATION; PATIENT COMPLIANCE; PHLEBITIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; THORACOTOMY; THROMBOCYTOPENIA; TUBE; VIDEO ASSISTED THORACOSCOPIC SURGERY; VOMITING; ADJUVANT CHEMOTHERAPY; COMPARATIVE STUDY; LUNG RESECTION; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PSYCHOSURGERY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PATIENT COMPLIANCE; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PSYCHOSURGERY; RETROSPECTIVE STUDIES; THORACIC SURGERY, VIDEO-ASSISTED; THORACOTOMY; TREATMENT OUTCOME;

EID: 83755173988     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-170     Document Type: Article

References (19)

1. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Chevalier TL. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE collaborative group. J Clin Oncol 2008, 26:3552-3559. 10.1200/JCO.2007.13.9030, 18506026.
2. Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7:719-727. 10.1016/S1470-2045(06)70804-X, 16945766.
3. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao MS, Gandara D, Kesler K, Demmy T, Shepherd F, , . National Cancer Institute of Canada Clinical Trials Group, National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005, 352:2589-2597. 10.1056/NEJMoa043623, 15972865, National Cancer Institute of Canada Clinical Trials Group, National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators.
4. Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study groups. J Clin Oncol 2008, 26:5043-5051. 10.1200/JCO.2008.16.4855, 2652093, 18809614.
5. Scott JS, Herndon J, Anthony D, Demmy T, Robert M, Green M, Sugarbaker D. Results of CALGB 39802: feasibility of video-assisted thoracic surgery (VATS) lobectomy for lung cancer. Proc Am Soc Clin Oncol 2002, 21:290a.
6. Nomori H, Ohtsuka T, Horio H, Naruke T, Suemasu K. Difference in the impairment of vital capacity and 6-minute walking after a lobectomy after a lobectomy performed by thoracoscopic surgery, an anterior limited thoracotomy, an antero-axillary thoracotomy, and a posterolateral thoracotomy. Surg Today 2003, 33:7-12. 10.1007/s005950300001, 12560900.
7. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg 2001, 72:362-365. 10.1016/S0003-4975(01)02804-1, 11515867.
8. Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009, 27:2553-2562. 10.1200/JCO.2008.18.2733, 19289625.
9. Flores RM, Park BJ, Dycoco J, Aronova A, Hirth Y, Rizk NP, Bains M, Downey RJ, Rusch VW. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2009, 138:11-18. 10.1016/j.jtcvs.2009.03.030, 19577048.
10. Handy JR, Asaph JW, Douville EC, Ott GY, Grunkemeier GL, Wu Y. Does video-assisted thoracoscopic lobectomy for lung cancer provide improved functional outcomes compared with open lobectomy?. Eur J Cardiothorac Surg 2010, 37:451-455.
11. McKenna RJ, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1100 cases. Ann Thorac Surg 2006, 81:421-426. 10.1016/j.athoracsur.2005.07.078, 16427825.
12. Onaitis MW, Petersen RP, Balderson SS, Toloza E, Burfeind WR, Harpole DH, D'Amico TA. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006, 244:420-425. 1856541, 16926568.
13. Wang J, Li Y, Liu J, Li JF, Jiang GC, Zhao H, Yang F, Liu YG, Zhou ZL, Bu L. Completely thoracoscopic lobectomy for early stage non-small-cell lung cancer. Chinese J Thorac Cardiovasc Surg 2008, 24:147-150.
14. Rapp E, Pater JL, Willan A, Cormier Y, Murray N, Evans WK, Hodson DI, Clark DA, Feld R, Arnold AM, Ayoub JI, Wilson KS, Latreille J, Wierzbicki RF, Hill DP. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol 1988, 6:633-641.
15. Petersen RP, Pham D, Burfeind WR, Hanish SI, Toloza EM, Harpole DH, D'Amico TA. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007, 83:1245-1249. discussion 1250., 10.1016/j.athoracsur.2006.12.029, 17383320.
16. Alam N, Shepherd FA, Winton T, Graham B, Johnson D, Livingston R, Rigas J, Whitehead M, Ding K, Seymour L. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 2005, 47:385-394. 10.1016/j.lungcan.2004.08.016, 15713522.
17. Nicastri DG, Wisnivesky JP, Litle VR, Yun J, Chin C, Dembitzer FR, Swanson SJ. Thoracoscopic lobectomy: Report on safety, discharge independence, pain, and chemotherapy tolerance. J Thorac Cardiovasc Surg 2008, 135:642-647. 10.1016/j.jtcvs.2007.09.014, 18329487.
18. Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006, 118:257-262. 10.1002/ijc.21496, 16231326.
19. Kosaka T, Yatabe Y, Onozato R, Kuwano H, Mitsudomi T. Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol 2009, 4:22-29. 10.1097/JTO.0b013e3181914111, 19096302.